4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 3.640
0.00 (0.00%)
Aug 28, 2026, 4:10 PM AEST
4DMedical Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -204.44 | -30.07 | -35.98 | -31.46 | -24.59 |
Depreciation & Amortization | 5.46 | 2.34 | 2.08 | 1.67 | 1.5 |
Other Amortization | - | 2.99 | 1.99 | 0.9 | - |
Loss (Gain) From Sale of Assets | - | -0.01 | - | - | - |
Asset Writedown & Restructuring Costs | - | 0.2 | 0.11 | 0.36 | 0.17 |
Stock-Based Compensation | - | 2.73 | 2.18 | 1.01 | 0.61 |
Provision & Write-off of Bad Debts | - | - | 0.01 | 0.04 | - |
Other Operating Activities | 167.7 | -0.45 | -0.83 | 0.02 | -0.33 |
Change in Accounts Receivable | - | -0.15 | -0.44 | -0.53 | -1.68 |
Change in Inventory | - | -0.07 | 0.33 | -0.66 | -0.27 |
Change in Accounts Payable | - | -1.29 | -1.2 | 3.06 | 0.31 |
Change in Unearned Revenue | - | -0.4 | 0.07 | 4.3 | -0.78 |
Change in Income Taxes | - | - | - | 0.32 | 0.04 |
Change in Other Net Operating Assets | - | -10.28 | 0.82 | -1.68 | -0.37 |
Operating Cash Flow | -31.27 | -34.48 | -30.87 | -22.65 | -25.27 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.95 | -0.09 | -0.16 | -0.42 | -2.65 |
Sale of Property, Plant & Equipment | - | 0.02 | - | - | - |
Cash Acquisitions | -0.03 | -0.3 | -38.87 | - | - |
Sale (Purchase) of Intangibles | -1.45 | -1.26 | -1.02 | -1.19 | -0.85 |
Investing Cash Flow | -2.43 | -1.62 | -40.04 | -1.61 | -3.5 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Issued | 10 | - | - | 1.34 | - |
Total Debt Issued | 10 | - | - | 1.34 | - |
Long-Term Debt Repaid | -1.2 | -0.97 | -1.01 | -1.17 | -1 |
Net Debt Issued (Repaid) | 8.8 | -0.97 | -1.01 | 0.17 | -1 |
Issuance of Common Stock | 309.18 | 14.7 | 35 | 45.09 | - |
Other Financing Activities | -13.2 | -1.36 | -2.05 | -2.53 | - |
Financing Cash Flow | 304.78 | 12.37 | 31.94 | 42.73 | -1 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash Flow | 271.08 | -23.73 | -38.97 | 18.46 | -29.77 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -32.22 | -34.56 | -31.02 | -23.07 | -27.92 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -456.34% | -590.45% | -826.34% | -3211.05% | -2647.86% |
Free Cash Flow Per Share | -0.01 | -0.08 | -0.08 | -0.08 | -0.09 |
Levered Free Cash Flow | -147.36 | -27.65 | -17.01 | -20.53 | -26.23 |
Unlevered Free Cash Flow | -44.48 | -27.5 | -16.85 | -20.34 | -26.12 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | 0.26 | 0.26 | 0.29 | 0.18 |
Change in Working Capital | - | -12.2 | -0.42 | 4.8 | -2.75 |